Research Article
Assessment of the Safety and Efficiency of a Preperitoneal Continuous Infusion Using Bupivacaine after Abdominal Laparotomy in Digestive Carcinology
Table 1
Demographic and clinical characteristics of patients (n = 60).
| | | Bupivacaine group (n = 30) | Saline group (n = 30) | value |
| | Residential location | 0.25 | | Urban | 25 | 27 | | Rural | 5 | 3 | | Sex | 0.53 | | Men | 14 | 13 | | Women | 16 | 17 | | Age | 55 ± 14 | 53 ± 13 | 0.47 | | ASA score | 0.16 | | ASAI/ASAII/ASAIII/ASAIV | 18/8/3/1 | 22/4/4/0 | | Diagnostic | 0.47 | | Ampullome vaterian | 7 | 6 | | Tumor of the pancreatic head | 5 | 6 | | Colon tumor | 4 | 3 | | Gastric tumor | 4 | 4 | | Esophagus tumor | 1 | 0 | | Duodenal tumor | 1 | 2 | | Sigmoidal and rectal tumor | 7 | 7 | | Gall bladder tumor | 1 | 2 | | Duration of intervention (h) | 5.7 ± 1.1 | 5.5 ± 1.4 | 0.51 | | Incision length (cm) | 15.5 ± 3.1 | 15.3 ± 3.9 | 0.88 |
|
|
ASA: American Society of Anesthesiologists (physical status classification system).
|
